Enjoy complimentary customisation on priority with our Enterprise License!
The stem cell manufacturing market share is expected to increase by USD 6.77 billion at a CAGR (Compound Annual Growth Rate) of 9.69% from 2021 to 2026.
The growth of the market depends on several factors such as the rising prevalence of several chronic disorders, and the growing demand for personalized medicines. The rates of certain diseases are on the rise across all socioeconomic classes due to lifestyle changes. This increase in disease prevalence will drive the demand for stem cells during the forecast period, leading to market growth. This market analysis and report also includes in-depth information on the key market drivers, trends, and challenges during the forecasted period.
| Study Period | 2022 |
| Base Year For Estimation |
2021 |
| CAGR | 9.69% |
| Forecast period |
2022-2026 |
| Fastest Growing Region |
42 of North America |
In company offerings, we provide an in-depth analysis of 20 top company profiles, along with other valuable insights comprising of:
? Company Overviews
? Key News and Updates
? Products and Services
? Market-leading Offerings
? Focused Segments
Becton Dickinson and Co. - The company offers a manufacturing kit namely the stem cell Enumeration kit.
These companies are adopting various strategies, including strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to strengthen their market presence. Collectively, they hold the largest market share and set industry trends
P and BC is the Leading Segment to Dominate the Market
The stem cell manufacturing market share growth by the P and BC segments will be significant during the forecast period. The a significant increase in the demand for stem cell manufacturing products in pharmaceutical and biotechnology companies to differentiate into certain cell types to be used as an effective tissue or disease model.
Stem Cell Manufacturing Market - Revenue Share by Deployment Segment, 2022-2026
42% of the market's growth will originate from North America during the forecast period. The US is the key market for manufacturing in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.
For more insights on the market share of various regions- Request Free Sample !
The presence of a well-developed healthcare system (which helps companies provide biotechnology solutions to easily establish themselves in the market) and the high disposable income (which allows people to opt for expensive therapies) will facilitate the market growth in North America in the forecast period. This market growth and forecasting report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for companies, which will assist in creating efficient business plans.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage. The Stem Cell Manufacturing Market is propelled by scientific discoveries and technological advancements in producing cells and tissues for therapeutic applications. This burgeoning sector encompasses the production of consumables and instruments vital for stem cell research and therapy. Spanning various geographical regions, the market witnesses the growing adoption of products like hematopoietic stem cells used in treating leukemia and epithelial stem cells for burns and corneal diseases. Stem cell manufacturing holds promise for addressing conditions like stroke, amyotrophic lateral sclerosis, and osteoarthritis, offering customized medicine solutions through stem cell therapy and genetic testing. However, navigating regulatory frameworks and operational expenditures while ensuring access to pharmaceutical medications and skilled professionals remain critical challenges. As the world grapples with rare disorders and cancer incidences, particularly in affluent countries, disruptions such as those caused by staff disruptions and regulatory scenarios underscore the need for resilient stem cell manufacturing practices.The rising prevalence of several chronic disorders is notably driving the market growth, although factors such as lack of trained professionals may impede the market growth. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
One of the key factors driving the global market growth is the rising prevalence of several chronic disorders. Four major chronic diseases are cardiovascular disease (CVD), cancer, chronic obstructive pulmonary disease, and type 2 diabetes, which occur due to high blood pressure, high blood cholesterol, overweight, physical inactivity, unhealthy diet, and use of tobacco. By 2022, chronic diseases are expected to rise to 72.94% of all deaths and 59.96% of the global burden of diseases. However, 78.92% of deaths related to these diseases occur in developing countries. Factors such as changing lifestyle patterns increase the rates of these diseases in all socioeconomic classes. The increase in the prevalence of these diseases will result in an increased demand for stem cells (iPSC), which, in turn, will drive the growth of the market in focus during the forecast period.
The key factor driving the market growth is the growing demand for personalized medicines. Personalized medicines can offer treatments based on the patient's characteristics, needs, and preferences. Hence, research organizations are exploring ways to develop personalized treatments by using mesenchymal cells owing to their multiple benefits such as the low risk of immune rejection, limited need for anti-rejection drugs, and fewer chances of developing graft-versus-host disease (GvHD). In addition, mesenchymal stem cells (MSCs) that are present in the vascular region of the bone marrow serve as the cellular support of the HSC niche. Therefore, the use of MSC during HSCT has improved the engraftment rate of hematopoietic cells by reducing the GvDH. Such factors are expected to support the market growth and trends in focus during the forecast period.
One of the key challenges to market growth is the lack of trained professionals to facilitate a successful procedure. For instance, multiple studies across the US have indicated a dire shortage of professionals, and at present, there are less than 5,000 genetic counselors available in the country. Furthermore, due to the lack of specific training programs for physicians, industry experts have predicted that the shortage of genetic experts is set to continue till 2024. According to the US Department of Labor (DOL), there has been a shortage of approximately 12,000-15,000 laboratory professionals across the country each year since 2014. Priorities in national healthcare systems, lack of access to genomic technologies, and differences in education and training systems among countries contribute to the inconsistent understanding of genomics data, which is expected to limit the market growth during the forecast period.
This market trends and analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The market witnesses substantial revenue driven by intensive research studies and industry trend analysis. Pricing and patent analyses, along with conference materials, inform buying behavior among key stakeholders. Growth factors include increased awareness of products, technical advancements, and regulatory policies. Stem cell banking, coupled with advanced laboratory equipment and facilities ensuring sterility, requires skilled personnel including scientists, technicians, and quality assurance experts.
In the realm of Regenerative Medicine, where scientific breakthroughs offer hope for treating various diseases and injuries such as Neurodegenerative disorders, Heart disease, and Organ failure, investors play a pivotal role. However, realizing the therapeutic potential of these advancements requires substantial funding and investment to cover operational costs, including those for research infrastructure, skilled workforce, and technological challenges. The adoption of regenerative medicine products hinges on navigating regulatory frameworks and addressing socioethical concerns. Despite hurdles, the promise of precision medicine and customized treatments for ailments like Alzheimer's disease, Parkinson's disease, Pluripotent stem and cancer incidences among the geriatric population spurs ongoing efforts in this field. As urbanization continues and healthcare expenditure rises, the quest for effective therapies persists, emphasizing the need for collaborative efforts in vaccine development, logistics planning, and data collection to address global health challenges comprehensively.
Government initiatives, especially in the biotechnology and biopharmaceutical sectors, drive investment through grants, tax incentives, and subsidies, fostering startups and small enterprises. Despite technical limitations, efforts focus on manufacturing scale-up and optimizing cell culture systems for consistent outcomes. Environmental factors such as temperature and oxygen levels are meticulously controlled with specialized equipment and infrastructure, ensuring the viability and efficacy of therapies and treatments.
|
We can help! Our analysts can customize this market research report to meet your requirements.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Deployment
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
